No Result
View All Result
SUBMIT YOUR ARTICLES
  • Login
Friday, October 3, 2025
TheAdviserMagazine.com
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal
No Result
View All Result
TheAdviserMagazine.com
No Result
View All Result
Home Medicare

Trump Won’t Force Medicaid to Cover GLP-1s for Obesity. A Few States Are Doing It Anyway.

by TheAdviserMagazine
5 months ago
in Medicare
Reading Time: 8 mins read
A A
Trump Won’t Force Medicaid to Cover GLP-1s for Obesity. A Few States Are Doing It Anyway.
Share on FacebookShare on TwitterShare on LInkedIn


CHARLESTON, S.C. — When Page Campbell’s doctor recommended she try an injectable prescription drug called Wegovy to lose weight before scheduling bariatric surgery, she readily agreed.

“I’ve struggled with my weight for so long,” said Campbell, 40, a single mother of two. “I’m not opposed to trying anything.”

In early April, about four weeks after she’d started taking Wegovy, Campbell said she hadn’t experienced any side effects, such as nausea or bowel irritation. But she doesn’t use a scale at home, she said, so she didn’t know whether she’d lost any weight since her most recent medical appointment earlier this year, when she weighed 314 pounds. Still, she was confident about achieving weight loss.

“It’s going to work because I’m putting in the work. I’m changing my eating habits. I’m exercising,” said Campbell, a shipping manager at a Michaels store. “I’m not going to second-guess myself.”

Wegovy belongs to a pricey class of drugs called GLP-1s (short for glucagon-like peptide-1 agonists) that have upended the treatment of obesity in recent years, offering hope to patients who have tried and failed to lose weight in myriad other ways.

Campbell gained access to Wegovy through South Carolina Medicaid’s decision in late 2024 to cover these weight loss drugs. But the medications remain out of reach for millions of patients across the country who could benefit from them, because many public and private health insurers have deemed the drugs too expensive.

A report published in November by KFF, a health information nonprofit that includes KFF Health News, found only 13 states were covering GLP-1s for the treatment of obesity for Medicaid beneficiaries as of August. South Carolina became the 14th in November.

Liz Williams, one of the report’s authors and a senior policy manager for the Program on Medicaid and the Uninsured at KFF, said she was not aware of any other state Medicaid programs joining the list since then. Looking ahead, the remaining states may be reluctant to add a new, expensive drug benefit while they brace for potential federal cuts coming from Congress, she said.

“As the budget debate, federally, is developing, that may impact how states are thinking about this,” Williams said.

Email Sign-Up

Subscribe to KFF Health News’ free Morning Briefing.

The federal government won’t be helping anytime soon, either. Medicare covers GLP-1s to treat diabetes and some other health conditions, including obstructive sleep apnea and cardiovascular disease, but not obesity. In early April, the Trump administration announced it will not finalize a rule proposed by the Biden administration that would have allowed an estimated 7.4 million people covered by Medicare and Medicaid to access GLP-1s for weight loss. Meanwhile, the FDA is poised to force less expensive, compounded versions of these drugs off the market.

And the barrier to entry remains high, even for Medicaid patients in those few states that have agreed to cover the drugs without a federal mandate.

Case in point: In South Carolina, where more than one-third of all adults, and nearly half of the African American population, qualify as obese, the state Medicaid agency estimates only 1,300 beneficiaries will meet the stringent prerequisites for GLP-1 coverage.

Under one of those requirements, Medicaid beneficiaries who wish to access these drugs to lose weight must attest to “increased exercise activity,” said Jeff Leieritz, a spokesperson for the South Carolina Department of Health and Human Services.

Campbell, who is insured by Medicaid, was granted coverage for Wegovy based on her body mass index. First, though, she was required to submit six months’ worth of documentation proving that she’d tried and failed to lose weight after receiving nutrition counseling and going on a 1,200-calorie-a day diet, said Kenneth Mitchell, one of Campbell’s doctors and the medical director for bariatric surgery and obesity medicine at Roper St. Francis Healthcare.

Campbell’s Wegovy prescription was approved for six months, Mitchell said. When that authorization expires, Campbell and her health care team will need to submit more documentation, including proof that she has lost at least 5% of her body weight and has kept up with nutrition counseling.

“It’s not just, ‘Send a prescription in and they cover it.’ It’s rather arduous,” Mitchell said. “Not a lot of folks are going to do this.”

Campbell, 40, a single mother of two, says she’s struggled with her weight so long that “I’m not opposed to trying anything.”(Andrew Whitaker for KFF Health News)
A close up a shot of a woman's face, who is smiling.
“Weight loss is my biggest goal,” says Campbell, who expressed appreciation for Medicaid’s coverage of Wegovy. “It’s one more thing that’s going to help me get to my goal.”(Andrew Whitaker for KFF Health News)

Mitchell said South Carolina Medicaid’s decision to cover these drugs was met with excitement among those working in his medical specialty. But he wasn’t surprised that the state anticipates relatively few people will access this benefit annually, since the approval process is so rigorous and the cost high. “The problem is the medicines are so expensive,” Mitchell said.

Novo Nordisk, which manufactures Wegovy, announced in March that it was cutting the monthly price for the drug from $650 to $499 for cash-paying customers. The price that health insurance plans and beneficiaries pay for these drugs varies, but some GLP-1s cost more than $1,000 per patient per month, Mitchell said, and many people will need to take them for the rest of their lives to maintain weight loss.

“That is a tremendous price tag that someone has to foot the bill for,” Mitchell said.

That’s the reason California Gov. Gavin Newsom on May 14 proposed eliminating Medicaid coverage of GLP-1s for weight loss starting Jan. 1, to save an estimated $680 million a year by 2028.

And the North Carolina State Health Plan Board of Trustees voted last year to end coverage of GLP-1s for state employees, after then-North Carolina Treasurer Dale Folwell’s office estimated in 2023 that the drugs were projected to cost the State Health Plan $1 billion over the next six years. The decision came only a few months after a separate North Carolina agency announced it would start covering these drugs for Medicaid beneficiaries. North Carolina Medicaid has estimated it will spend $16 million a year on GLP-1s.

South Carolina Medicaid, which insures fewer than half the number of people enrolled in North Carolina Medicaid, anticipates spending less. Leieritz estimated GLP-1s and nutrition counseling offered to Medicaid beneficiaries in South Carolina will cost $10 million a year. State funding will cover $3.3 million of the expense; the remainder will be paid for by matching Medicaid funds from the federal government.

In a recent interview, Health and Human Services Secretary Robert F. Kennedy Jr. didn’t rule out the possibility that Medicare and Medicaid might cover GLP-1s for obesity treatment in the future as costs come down.

They’re “extraordinary drugs” and “we’re going to reduce the cost,” Kennedy told CBS News in early April. He said he would like GLP-1s to eventually be made available to Medicare and Medicaid patients who are seeking obesity treatment after they have tried other ways to lose weight. “That is the framework that we’re now debating.”

Meanwhile, public health experts have applauded South Carolina Medicaid’s decision to cover GLP-1s. Yet the new benefit won’t help the vast majority of the 1.5 million adults in South Carolina who are classified as obese, according to data published by the South Carolina Department of Public Health.

“We still have some work to do,” acknowledged Brannon Traxler, the public health department’s chief medical officer.

But the state’s new “Action Plan for Healthy Eating and Active Living,” written by a coalition of groups in South Carolina, including the Department of Public Health, makes no mention of GLP-1s or the role they might play in lowering obesity rates in the state.

The action plan, underwritten by a $1.5 million federal grant, isn’t meant to lay out an overarching approach for lowering obesity in South Carolina, Traxler said. Instead, it promotes physical activity in schools, nutrition, and the expansion of outdoor walking trails, among other strategies. A more comprehensive obesity plan might address the benefits of surgical intervention and GLP-1s, but those also carry risk, expense, and side effects, Traxler said.

“Certainly, I think, there is a need to bring it all together,” she said.

Campbell, for one, is taking the comprehensive approach. On top of injecting Wegovy once weekly, she said, she is prioritizing protein intake and moving her body. She also underwent weight loss surgery in late April.

“Weight loss is my biggest goal,” said Campbell, who expressed appreciation for Medicaid’s coverage of Wegovy. “It’s one more thing that’s going to help me get to my goal.”

Lauren Sausser:
[email protected],
@laurenmsausser

Related Topics

Contact Us

Submit a Story Tip



Source link

Tags: coverforceGLP1sMedicaidobesityStatesTrumpWont
ShareTweetShare
Previous Post

Philanthropy CEO: Silicon Valley entrepreneurs who think they can cure poverty are a red flag

Next Post

NBFC stocks: NBFCs and OMC stocks offer margin of safety amid sector rotation: Rohit Srivastava

Related Posts

edit post
Federal Government Shuts Down Over Health Care Subsidies

Federal Government Shuts Down Over Health Care Subsidies

by TheAdviserMagazine
October 2, 2025
0

The federal government is currently in a shutdown triggered by a lack of bipartisan agreement on government funding and access...

edit post
The Struggle To Afford Insurance in 2026 Hits Home

The Struggle To Afford Insurance in 2026 Hits Home

by TheAdviserMagazine
October 1, 2025
0

Dan Weissmann “An Arm and a Leg” senior producer Emily Pisacreta recently lost a job that provided her with health...

edit post
Health insurance for the unemployed

Health insurance for the unemployed

by TheAdviserMagazine
September 28, 2025
0

In the United States, nearly half of the people under the age of 65 get their health insurance from an...

edit post
Journalists Recap Coverage on Organ Harvesting, Obamacare, and Medicaid Cuts

Journalists Recap Coverage on Organ Harvesting, Obamacare, and Medicaid Cuts

by TheAdviserMagazine
September 27, 2025
0

KFF Health News Midwest correspondent Cara Anthony discussed problems with the organ transplantation industry on Apple News’ “Apple News Today”...

edit post
Listen: Young Adults Turning 26 Face Health Insurance Cliff

Listen: Young Adults Turning 26 Face Health Insurance Cliff

by TheAdviserMagazine
September 26, 2025
0

Thank you for your interest in supporting KFF Health News, the nation’s leading nonprofit newsroom focused on health and health...

edit post
Federal Funding Deadline Looms – Medicare Rights Center

Federal Funding Deadline Looms – Medicare Rights Center

by TheAdviserMagazine
September 25, 2025
0

Legislation funding the federal government expires September 30. Congress must pass another spending bill by then to avoid a shutdown,...

Next Post
edit post
NBFC stocks: NBFCs and OMC stocks offer margin of safety amid sector rotation: Rohit Srivastava

NBFC stocks: NBFCs and OMC stocks offer margin of safety amid sector rotation: Rohit Srivastava

edit post
Crypto.com Exchange Acquires CySEC-regulated Broker, Plans to Offer CFDs in Q3 2025

Crypto.com Exchange Acquires CySEC-regulated Broker, Plans to Offer CFDs in Q3 2025

  • Trending
  • Comments
  • Latest
edit post
What Happens If a Spouse Dies Without a Will in North Carolina?

What Happens If a Spouse Dies Without a Will in North Carolina?

September 14, 2025
edit post
California May Reimplement Mask Mandates

California May Reimplement Mask Mandates

September 5, 2025
edit post
Does a Will Need to Be Notarized in North Carolina?

Does a Will Need to Be Notarized in North Carolina?

September 8, 2025
edit post
DACA recipients no longer eligible for Marketplace health insurance and subsidies

DACA recipients no longer eligible for Marketplace health insurance and subsidies

September 11, 2025
edit post
‘Quiet luxury’ is coming for the housing market, The Corcoran Group CEO says. It’s not just the Hamptons, Aspen, and Miami anymore

‘Quiet luxury’ is coming for the housing market, The Corcoran Group CEO says. It’s not just the Hamptons, Aspen, and Miami anymore

September 9, 2025
edit post
Tips to Apply for Mental Health SSDI Without Therapy

Tips to Apply for Mental Health SSDI Without Therapy

September 19, 2025
edit post
Axos Basic Business Checking Review – Best Fee-Free Business Account in 2025?

Axos Basic Business Checking Review – Best Fee-Free Business Account in 2025?

0
edit post
How startups could be affected by a prolonged government shutdown

How startups could be affected by a prolonged government shutdown

0
edit post
Hydrogen Fueling Station Market Growth Outlook & Investment Opportunities

Hydrogen Fueling Station Market Growth Outlook & Investment Opportunities

0
edit post
SmartAsset study explores RIAs with B in client assets

SmartAsset study explores RIAs with $1B in client assets

0
edit post
Deutsche Bank Starts Covering Array Technologies, Inc. (ARRY) with Buy Rating and  Price Target

Deutsche Bank Starts Covering Array Technologies, Inc. (ARRY) with Buy Rating and $11 Price Target

0
edit post
New Hires Fell To 16-Year Low In September

New Hires Fell To 16-Year Low In September

0
edit post
Hydrogen Fueling Station Market Growth Outlook & Investment Opportunities

Hydrogen Fueling Station Market Growth Outlook & Investment Opportunities

October 3, 2025
edit post
La Fondazione Ethereum svela la prossima fase della sua rivoluzione sulla privacy

La Fondazione Ethereum svela la prossima fase della sua rivoluzione sulla privacy

October 3, 2025
edit post
Earnings momentum, banks and discretionary consumption to drive market upside: Tushar Bohra

Earnings momentum, banks and discretionary consumption to drive market upside: Tushar Bohra

October 3, 2025
edit post
Tesla vehicle sales made a comeback last quarter. Will a lost EV tax credit end the rebound?

Tesla vehicle sales made a comeback last quarter. Will a lost EV tax credit end the rebound?

October 3, 2025
edit post
Investor education key to counter get-rich-quick culture: Sunil Subramaniam

Investor education key to counter get-rich-quick culture: Sunil Subramaniam

October 3, 2025
edit post
BNB Leads Crypto Market Rally With Fresh All-Time High, Expert Sees 00 Upside

BNB Leads Crypto Market Rally With Fresh All-Time High, Expert Sees $5000 Upside

October 3, 2025
The Adviser Magazine

The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.

CATEGORIES

  • 401k Plans
  • Business
  • College
  • Cryptocurrency
  • Economy
  • Estate Plans
  • Financial Planning
  • Investing
  • IRS & Taxes
  • Legal
  • Market Analysis
  • Markets
  • Medicare
  • Money
  • Personal Finance
  • Social Security
  • Startups
  • Stock Market
  • Trading

LATEST UPDATES

  • Hydrogen Fueling Station Market Growth Outlook & Investment Opportunities
  • La Fondazione Ethereum svela la prossima fase della sua rivoluzione sulla privacy
  • Earnings momentum, banks and discretionary consumption to drive market upside: Tushar Bohra
  • Our Great Privacy Policy
  • Terms of Use, Legal Notices & Disclosures
  • Contact us
  • About Us

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.